|
|
| Frequency | % |
| Age (years) | Mean ± SD | 51.2 ± 9.9 (Range: 33 - 72 years) |
|
| BMI | Mean ± SD | 28 ± 9.4 |
|
| Residence | Urban | 13 | 39.3% |
|
| Rural | 20 | 60.6% |
| Tumor Type | IDC | 33 | 100.0% |
| Ductal carcinoma in situ (DCIS) | No | 20 | 60.6% |
| Yes | 13 | 39.4% | |
| Desmoplastic reaction | None | 13 | 39.4% |
| Mild | 8 | 24.2% | |
| Moderate | 7 | 21.2% | |
| Marked | 5 | 15.2% | |
| Lymph Nodes involvement | No | 12 | 36.4% |
| Yes | 21 | 63.6% | |
| Largest Tumor diameters | Mean (SD) | 4.0 (2.4) |
|
| Tumor Stage | IA | 2 | 6.1% |
| IIA | 7 | 21.2% | |
| IIB | 8 | 24.2% | |
| IIIA | 3 | 9.1% | |
| IIIC | 2 | 6.1% | |
| IV | 11 | 33.3% | |
| Tumor Grade | I | 1 | 3.0% |
| II | 31 | 93.9% | |
| III | 1 | 3.0% | |
| Estrogen Receptors (ER) | Negative | 10 | 30.3% |
| Positive | 23 | 69.7% | |
| Progesterone Receptors (PR) | Negative | 10 | 30.3% |
| Positive | 23 | 69.7% |